INTEGRATED BIOPHARMA INC Revenue, Net (Deprecated 2018-01-31)
INTEGRATED BIOPHARMA INC (INBP) reported Revenue, Net (Deprecated 2018-01-31) of $10.80 million for the 3-month period ending 2017-12-31, per its 10-Q filed 2018-02-09.
Discontinued › Income Statement › Revenue
us-gaap:SalesRevenueNet · last filed 2018-02-09
- INTEGRATED BIOPHARMA INC revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $10.80M, a 12.71% decline year-over-year.
- INTEGRATED BIOPHARMA INC revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $9.77M, a 22.96% decline year-over-year.
- INTEGRATED BIOPHARMA INC revenue, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $11.25M, a 1.20% decline year-over-year.
- INTEGRATED BIOPHARMA INC revenue, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $10.65M, a 2.89% decline year-over-year.
- INTEGRATED BIOPHARMA INC revenue, net (deprecated 2018-01-31) for fiscal 2017 was $46.95M, a 11.23% increase from fiscal 2016.
- INTEGRATED BIOPHARMA INC revenue, net (deprecated 2018-01-31) for fiscal 2016 was $42.21M, a 12.61% increase from fiscal 2015.
- INTEGRATED BIOPHARMA INC revenue, net (deprecated 2018-01-31) for fiscal 2015 was $37.49M, a 11.30% increase from fiscal 2014.
- INTEGRATED BIOPHARMA INC revenue, net (deprecated 2018-01-31) for fiscal 2014 was $33.68M.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $10.80M 10-Q · filed 2018-02-09 | $20.57M 10-Q · filed 2018-02-09 | $31.82M derived: sum of 3 quarters · filed 2018-02-09 | $42.47M derived: sum of 4 quarters · filed 2018-02-09 |
| 2017-09-30 | $9.77M 10-Q · filed 2017-11-09 | $21.02M derived: sum of 2 quarters · filed 2017-11-09 | $31.67M derived: sum of 3 quarters · filed 2017-11-09 | $44.04M derived: sum of 4 quarters · filed 2018-02-09 |
| 2017-06-30 | $11.25M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-01 | $21.90M derived: sum of 2 quarters · filed 2017-09-01 | $34.27M derived: sum of 3 quarters · filed 2018-02-09 | $46.95M 10-K · filed 2017-09-01 |
| 2017-03-31 | $10.65M 10-Q · filed 2017-05-10 | $23.03M derived: sum of 2 quarters · filed 2018-02-09 | $35.71M 10-Q · filed 2017-05-10 | $47.09M derived: sum of 4 quarters · filed 2018-02-09 |
| 2016-12-31 | $12.37M 10-Q · filed 2018-02-09 | $25.05M 10-Q · filed 2018-02-09 | $36.44M derived: sum of 3 quarters · filed 2018-02-09 | $47.41M derived: sum of 4 quarters · filed 2018-02-09 |
| 2016-09-30 | $12.68M 10-Q · filed 2017-11-09 | $24.07M derived: sum of 2 quarters · filed 2017-11-09 | $35.04M derived: sum of 3 quarters · filed 2017-11-09 | $45.45M derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | $11.38M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-01 | $22.36M derived: sum of 2 quarters · filed 2017-09-01 | $32.77M derived: sum of 3 quarters · filed 2017-09-01 | $42.21M 10-K · filed 2017-09-01 |
| 2016-03-31 | $10.97M 10-Q · filed 2017-05-10 | $21.38M derived: sum of 2 quarters · filed 2017-05-10 | $30.83M 10-Q · filed 2017-05-10 | $39.77M derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | $10.41M 10-Q · filed 2017-02-10 | $19.86M 10-Q · filed 2017-02-10 | $28.80M derived: sum of 3 quarters · filed 2017-02-10 | $38.47M derived: sum of 4 quarters · filed 2017-02-10 |
| 2015-09-30 | $9.45M 10-Q · filed 2016-11-10 | $18.39M derived: sum of 2 quarters · filed 2016-11-10 | $28.06M derived: sum of 3 quarters · filed 2016-11-10 | $38.35M derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | $8.94M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-02 | $18.61M derived: sum of 2 quarters · filed 2016-09-02 | $28.91M derived: sum of 3 quarters · filed 2016-09-02 | $37.49M 10-K · filed 2016-09-02 |
| 2015-03-31 | $9.67M 10-Q · filed 2016-05-13 | $19.96M derived: sum of 2 quarters · filed 2016-05-13 | $28.54M 10-Q · filed 2016-05-13 | $36.73M derived: sum of 4 quarters · filed 2016-05-13 |
| 2014-12-31 | $10.29M 10-Q · filed 2016-02-19 | $18.87M 10-Q · filed 2016-02-19 | $27.05M derived: sum of 3 quarters · filed 2016-02-19 | $34.58M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-09-30 | $8.58M 10-Q · filed 2015-11-05 | $16.76M derived: sum of 2 quarters · filed 2015-11-05 | $24.29M derived: sum of 3 quarters · filed 2015-11-05 | $33.07M derived: sum of 4 quarters · filed 2015-11-05 |
| 2014-06-30 | $8.18M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-04 | $15.70M derived: sum of 2 quarters · filed 2015-09-04 | $24.49M derived: sum of 3 quarters · filed 2015-09-04 | $33.68M 10-K · filed 2015-09-04 |
| 2014-03-31 | $7.52M 10-Q · filed 2015-05-14 | $16.31M derived: sum of 2 quarters · filed 2015-05-14 | $25.50M 10-Q · filed 2015-05-14 | |
| 2013-12-31 | $8.79M 10-Q · filed 2015-02-17 | $17.98M 10-Q · filed 2015-02-17 | ||
| 2013-09-30 | $9.19M 10-Q · filed 2013-11-14 | |||
| 2012-09-30 | $8.48M 10-Q · filed 2013-11-14 |